Stay updated with breaking news from Azurity Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Azurity Pharmaceuticals, Inc. is recalling one lot of Zenzedi CII (dextroamphetamine sulfate tablets, USP) 30 mg to the consumer level, according to the U.S. Food and Drug Administration.
QHP Capital, which started as a corporate venture arm of Quintiles (now IQVIA) and later spun out as NovaQuest that raised $500 million under its ......
NEW YORK, June 20, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the appointment... | June 20, 2023
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s ...